Royal Bank Of Canada Applied Molecular Transport Inc. Transaction History

Royal Bank Of Canada

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.16 - $0.34 $69 - $146	-432 Reduced 46.4%	499 $0
Q2 2023 Aug 14, 2023	BUY	$0.24 - $0.37 $222 - $342	926 Added 18520.0%	931 $0
Q4 2022 Feb 14, 2023	SELL	$0.35 - $1.26 $76 - $275	-219 Reduced 97.77%	5 $0
Q3 2022 Nov 14, 2022	BUY	$1.12 - $3.12 $250 - $698	224 New	224 $0
Q2 2022 Aug 15, 2022	SELL	$2.76 - $7.65 $4,242 - $11,758	-1,537 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$5.63 - $13.88 $20,915 - $51,564	-3,715 Reduced 70.73%	1,537 $12,000
Q4 2021 Feb 14, 2022	BUY	$13.23 - $26.05 $41,767 - $82,239	3,157 Added 150.69%	5,252 $73,000
Q3 2021 Nov 15, 2021	BUY	$25.87 - $46.61 $10,658 - $19,203	412 Added 24.48%	2,095 $54,000
Q2 2021 Aug 16, 2021	BUY	$39.76 - $64.31 $66,916 - $108,233	1,683 New	1,683 $77,000

9.42K

Ticker AMTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,900,600
Description
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of r...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.